GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Pre-Tax Income

Alto Neuroscience (Alto Neuroscience) Pre-Tax Income : $-24.63 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Alto Neuroscience's pretax income for the three months ended in Mar. 2024 was $-13.42 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-24.63 Mil. Alto Neuroscience's pretax margin was %.

During the past 3 years, Alto Neuroscience's highest Pretax Margin was -4374.76%. The lowest was -4374.76%. And the median was -4374.76%.

Alto Neuroscience Pre-Tax Income Historical Data

The historical data trend for Alto Neuroscience's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Pre-Tax Income Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Pre-Tax Income
-9.19 -27.71 -36.31

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial -7.65 -7.28 - -11.22 -13.42

Competitive Comparison of Alto Neuroscience's Pre-Tax Income

For the Biotechnology subindustry, Alto Neuroscience's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alto Neuroscience's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alto Neuroscience's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Alto Neuroscience's Pre-Tax Income falls into.


Alto Neuroscience Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Alto Neuroscience's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-37.809+0.525+-1.37+2.349+-7.105427357601E-15
=-36.31

Alto Neuroscience's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-14.386+-0.243+-0.346+1.558+0
=-13.42

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience  (NYSE:ANRO) Pre-Tax Income Explanation

Alto Neuroscience's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-13.417/0
=%

During the past 3 years, Alto Neuroscience's highest Pretax Margin was -4374.76%. The lowest was -4374.76%. And the median was -4374.76%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Pre-Tax Income
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024